Business
Digipath Name and Symbol Change Approved, Company Begins Trading as Hypha Labs, Inc. (FUNI)
Digipath Name and Symbol Change Approved, Company Begins Trading as Hypha Labs, Inc. (FUNI).
About this update from Hypha Labs, Inc.
[{"type":"text","content":"LAS VEGAS, NV / ACCESSWIRE / August 13, 2024 / Hypha Labs, Inc. formerly (OTC PINK:DIGP), has been approved to commence trading as Hypha Labs, Inc. (OTC PINK:FUNI) on August 13, 2024. Hypha Labs has developed the first in-home mushroom accelerator to allow for the production of high quality mushroom ingredients in just eight days."We are pleased to at last align our corporate name and ticker with our pioneering operations in the development of a suite of functional mushroom ingredient accelerators for home and commercial use," stated Stone Douglass, CEO, Hypha Labs. "We've been working diligently to perfect our accelerator and to prepare to fully exploit the vast opportunity for the in-home production of a wide array of mushroom ingredients.""As the clever Keurig was to coffee, Hypha Labs aspires to be that change agent for people who want to produce their own consistent ingredients from the comfort and privacy of their home kitchens," added Douglass.About Hypha Labs, Inc.The company has developed revolutionary cutting-edge technology focused on new methods of producing the active ingredients found in functional mushrooms such as psilocybin using its patent-pending bioreactor design. The Company has positioned itself to play an important role in the burgeoning Functional Mushroom industry in addition to being a disruptive force in the psilocybin space which is quickly manifesting into a similar pattern that was seen in the Cannabis Industry both from a medical and recreational usage with several states and cities have now decriminalized it use. Visit us at HyphaLabs.com.SAFE HARBOR FORWARD LOOKING STATEMENTS:This press release may contain forward looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of...